TerrAscend (TSNDF) Non-Current Deferred Tax Liability (2021 - 2026)

TerrAscend's (TSNDF) quarterly Non-Current Deferred Tax Liability came in at $8.3 million in Q1 2026, down 6.3% year-on-year from $8.9 million in Q1 2025, and up 3.74% on a QoQ basis from $8.0 million in Q4 2025.

TerrAscend (TSNDF) Non-Current Deferred Tax Liability (2021 - 2026) Analysis & Trends

TerrAscend (TSNDF) has 6 years of Non-Current Deferred Tax Liability data on file, last reported at $8.3 million in Q1 2026.

  • On a quarterly basis, Non-Current Deferred Tax Liability fell 6.3% year-over-year to $8.3 million in Q1 2026; TTM through Mar 2026 was $8.3 million, a 6.3% decrease from a year earlier, with the FY2025 full-year figure at $8.0 million, down 4.78% from the prior year.
  • Non-Current Deferred Tax Liability for Q1 2026 stood at $8.3 million, up from $8.0 million in the prior quarter.
  • Over the last five years, Non-Current Deferred Tax Liability for TSNDF reached as high as $73.1 million in Q2 2022 and fell as low as $8.0 million in Q4 2025.
  • Historically, Non-Current Deferred Tax Liability has averaged $26.1 million across 5 years, with a median of $16.9 million in 2024.
  • Across the five-year window, Non-Current Deferred Tax Liability surged 115.15% in 2022 and plunged 57.68% in 2024, its largest moves.
  • Year by year, Non-Current Deferred Tax Liability stood at $30.7 million in 2022, then tumbled by 44.06% to $17.2 million in 2023, then plunged by 50.93% to $8.4 million in 2024, then slipped by 4.78% to $8.0 million in 2025, then rose by 3.74% to $8.3 million in 2026.
  • Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $8.3 million in Q1 2026, $8.0 million in Q4 2025, and $8.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 TerrAscend 160.44 Mn 162.98 Mn 34.60 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 8.33 Mn
Mar 31, 2026 8.33 Mn
Dec 31, 2025 8.03 Mn
Dec 31, 2025 8.03 Mn
Sep 30, 2025 8.72 Mn
Sep 30, 2025 8.72 Mn
Jun 30, 2025 9.03 Mn
Jun 30, 2025 9.03 Mn
Mar 31, 2025 8.89 Mn
Mar 31, 2025 8.89 Mn
Dec 31, 2024 8.43 Mn
Dec 31, 2024 8.43 Mn
Sep 30, 2024 16.19 Mn
Sep 30, 2024 16.19 Mn
Jun 30, 2024 16.76 Mn
Jun 30, 2024 16.76 Mn
Mar 31, 2024 16.92 Mn
Mar 31, 2024 16.92 Mn
Dec 31, 2023 17.18 Mn
Dec 31, 2023 17.18 Mn